跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,723 条关于
“ARCT-154”
全部
6,723
临床试验
5,167
药物
1,003
机构
18
资讯
535
去年
Arcturus/CSL COVID-19 Vaccine Shows Enhanced, Durable Immune Response Compared to Comirnaty
去年
Self-Amplifying mRNA Vaccines Face Slow Adoption Despite Promise
去年
First Self-Amplifying mRNA COVID-19 Vaccine KOSTAIVE Receives European Commission Approval
11个月前
Arcturus Therapeutics' Inhaled mRNA Therapy ARCT-032 Shows Mixed Results in Phase 2 Cystic Fibrosis Trial
去年
Zhimeng Biopharma's CB03-154 Receives Chinese Regulatory Approval for ALS Phase 2/3 Trial
去年
Arcturus Therapeutics to Present Phase 2 Data for ARCT-810 mRNA Therapy in Rare Genetic Disorder
2年前
Arcturus Therapeutics Announces Positive Clinical Updates and Financial Results for Q1 2024
去年
Arcturus Therapeutics Initiates Phase 2 Trials for mRNA Therapies Targeting Cystic Fibrosis and OTC Deficiency
去年
Arcturus Therapeutics Poised for Growth with Cystic Fibrosis and OTCD Therapies
去年
Arcturus Therapeutics' COVID-19 Vaccine Kostaive Receives Positive EMA Recommendation
第 1 页,共 54 页
上一页
下一页